This is a randomized controlled human exposure crossover study. Investigators aims to assess the acute effects of high temperature exposure and the underlying mechanisms.
Age range
18 Years – 30 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Systolic and diastolic blood pressure
Timeframe: Systolic and diastolic blood pressure will be measured within 15 minutes before exposure and immediately after the exposure session, and every 15 minutes during exposure.
Cardiac output
Timeframe: Cardiac output will be checked within half an hour before exposure and immediately after exposure.
Heart rate variability
Timeframe: Cardiac variability will be monitored in real time from half an hour before exposure to half an hour after exposure, with data automatically recorded every 8 seconds.
Change of forced expired volume in the first second (FEV1)
Timeframe: FEV1 will be checked within half an hour before exposure and 15 minutes after exposure.
Changes of forced vital capacity (FVC)
Timeframe: FVC will be checked within half an hour before exposure and 15 minutes after exposure.
Changes of peak expiratory flow rate (PEF)
Timeframe: PEF will be checked within half an hour before exposure and 15 minutes after exposure.
Changes of maximum expiratory flow rate at 25% vital capacity (MEF25)
Timeframe: MEF25 will be checked within half an hour before exposure and 15 minutes after exposure.
Changes of maximum expiratory flow rate at 50% vital capacity (MEF50)
Timeframe: MEF50 will be checked within half an hour before exposure and 15 minutes after exposure.
Changes of maximum expiratory flow rate at 75% vital capacity (MEF75)
Timeframe: MEF75 will be checked within half an hour before exposure and 15 minutes after exposure.
Inflammatory factors and antioxidant-related biomarkers in nasal cavity fluid
Timeframe: Collect nasal fluid samples half an hour before exposure and half an hour after exposure